|
GB0514967D0
|
|
Treating ovarian cancer
|
|
AU6778001A
|
|
Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
|
|
IL148351D0
|
|
Therapeutic immune condition compositions and methods
|
|
IL148165D0
|
|
Therapeutic antibody against muc-1 antigen and methods for their use
|
|
WO0112217A1
|
|
Therapeutic antibody against muc-1 antigen and methods for their use
|
|
US6716966B1
|
|
Therapeutic binding agents against MUC-1 antigen and methods for their use
|
|
IL139832D0
|
|
Therapeutic compositions that produce an immune response by altering the antigen
|
|
ZA9810275B
|
|
Therapeutic compositions that produce an immune response.
|
|
CA2253058A1
|
|
Therapeutic composition that produce and immune response
|
|
US7361346B1
|
|
Therapeutic compositions that produce an immune response
|
|
WO9857661A1
|
|
Therapeutic composition and method of treatment
|
|
KR20000011003A
|
|
Method and composition for reconforming multi-epitopic antigens to initiate an immune response
|
|
CN1217661A
|
|
Method and composition for reconforming multi-epitopic antigens to initiate immune response
|
|
NZ503032A
|
|
Use of a binding agent to reconforming multi-epitopic antigens to initiate an immune response
|
|
JPH11509558A
|
|
Method and composition for reconstituting an antigen containing multiple epitopes to elicit an immune response
|
